Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016

Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016

Bibliographic Details
Main Authors:	Khalil, IA, Troeger, C, Blacker, BF, Rao, PC, Brown, A, Atherly, DE, Brewer, TG, Engmann, CM, Houpt, ER, Kang, G, Kotloff, KL, Levine, MM, Luby, SP, Maclennan, CA, Pan, WK, Pavlinac, PB, Platts-Mills, JA, Qadri, F, Riddle, MS, Ryan, ET, Shoultz, DA, Steele, AD, Walson, JL, Sanders, JW, Mokdad, AH, Murray, CJL, Hay, SI, Reiner, RC
Format:	Journal article
Language:	English
Published:	Elsevier 2018

Similar Items

Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: A meta-analyses study
by: Khalil, I, et al.
Published: (2018)

Identification and management of Shigella infection in children with diarrhoea: a systematic review and meta-analysis
by: Kirkby D Tickell, DrMBBS, et al.
Published: (2017-12-01)

Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017
by: Troeger, CE, et al.
Published: (2019)

Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints
by: Maclennan, C, et al.
Published: (2019)

Pivotal <i>Shigella</i> Vaccine Efficacy Trials—Study Design Considerations from a <i>Shigella</i> Vaccine Trial Design Working Group
by: Patricia B. Pavlinac, et al.
Published: (2022-03-01)

A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology.
by: Lorenz von Seidlein, et al.
Published: (2006-09-01)

Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study
by: Ibrahim A Khalil, MD, et al.
Published: (2018-07-01)

Critical needs in advancing Shigella vaccines for global health
by: MacLennan, CA, et al.
Published: (2021)

Shigella in Brazilian children with acute diarrhoea: prevalence, antimicrobial resistance and virulence genes
by: Mireille Ângela Bernardes Sousa, et al.
Published: (2013-02-01)

Shigella in Brazilian children with acute diarrhoea: prevalence, antimicrobial resistance and virulence genes
by: Mireille Ângela Bernardes Sousa, et al.
Published: (2013-02-01)

Evaluation of a simple, rapid and field-adapted diagnostic assay for enterotoxigenic E. coli and Shigella.
by: Sean Connor, et al.
Published: (2022-02-01)

Consequences of Shigella infection in young children: a systematic review
by: Tanya E. Libby, et al.
Published: (2023-04-01)

Shigella infection in children and adults: a formidable foe
by: Karen L Kotloff
Published: (2017-12-01)

Detection of Enterotoxigenic <i>Escherichia coli</i> and Clostridia in the Aetiology of Neonatal Piglet Diarrhoea: Important Factors for Their Prevention
by: Nikolaos Tsekouras, et al.
Published: (2023-04-01)

Microencapsulated probiotic Lactiplantibacillus plantarum and/or Pediococcus acidilactici strains ameliorate diarrhoea in piglets challenged with enterotoxigenic Escherichia coli
by: Pawiya Pupa, et al.
Published: (2022-05-01)

How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella?
by: Giersing, B, et al.
Published: (2019)

Infectious drug resistance and antibiotic resistance curing in Salmonella and Shigella isolates from cases of diarrhoea
by: A.I. Adetosoye, et al.
Published: (1985-04-01)

Clinical manifestations and microbiology of Shigella diarrhoea in children admitted to Teaching Hospital, Jaffna, Sri Lanka
by: MG Sathiadas, et al.
Published: (2016-10-01)

Derivation and external validation of a clinical prognostic model identifying children at risk of death following presentation for diarrheal care
by: Ahmed, SM, et al.
Published: (2023)

Global disability-adjusted life-year estimates of long-term health burden and undernutrition attributable to diarrhoeal diseases in children younger than 5 years
by: Troeger, C, et al.
Published: (2018)

Field evaluation of a simple and rapid diagnostic test, RLDT to detect Shigella and enterotoxigenic E. coli in Indian children
by: Goutam Chowdhury, et al.
Published: (2024-04-01)

Development of a simple, rapid, and sensitive diagnostic assay for enterotoxigenic E. coli and Shigella spp applicable to endemic countries.
by: Subhra Chakraborty, et al.
Published: (2022-01-01)

Impact of early inoculation of probiotics to suckling piglets on postweaning diarrhoea – A challenge study with Enterotoxigenic E. Coli F18
by: L.H.B Hansen, et al.
Published: (2022-11-01)

Burden of diarrhea and antibiotic use among children in low-resource settings preventable by Shigella vaccination: A simulation study.
by: Stephanie A Brennhofer, et al.
Published: (2023-11-01)

Community-acquired diarrhoea in a world with rotavirus vaccine: a glimpse into the future
by: Kathleen M Neuzil, et al.
Published: (2015-09-01)

Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017
by: Troeger, CE, et al.
Published: (2019)

Frontiers in <i>Shigella</i> Vaccine Development
by: Calman Alexander MacLennan, et al.
Published: (2022-09-01)

Burden, Antibiotic Resistance, and Clonality of <i>Shigella</i> spp. Implicated in Community-Acquired Acute Diarrhoea in Lilongwe, Malawi
by: Abel F.N.D. Phiri, et al.
Published: (2021-04-01)

The effect of acute malnutrition on enteric pathogens, moderate-to-severe diarrhoea, and associated mortality in the Global Enteric Multicenter Study cohort: a post-hoc analysis
by: Kirkby D Tickell, MBBS, et al.
Published: (2020-02-01)

The <i>Shigella</i> Vaccines Pipeline
by: Calman Alexander MacLennan, et al.
Published: (2022-08-01)

Clonal relatedness of enterotoxigenic Escherichia coli (ETEC) strains expressing LT and CS17 isolated from children with diarrhoea in La Paz, Bolivia.
by: Claudia Rodas, et al.
Published: (2011-01-01)

Could a Shigella vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a Shigella vaccine public health value proposition, March 24 and 29, 2021
by: Karoun H. Bagamian, et al.
Published: (2022-12-01)

Consensus report on Shigella controlled human infection model: introduction and overview
by: Maclennan, CA, et al.
Published: (2019)

Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis
by: John D Anderson, IV, PhD, et al.
Published: (2019-03-01)

Conservation and immunogenicity of novel antigens in diverse isolates of enterotoxigenic Escherichia coli.
by: Qingwei Luo, et al.
Published: (2015-01-01)

Consensus report on Shigella controlled human infection model: Immunological assays
by: Kaminski, R, et al.
Published: (2019)

Efficacy of neomycin dosing regimens for treating enterotoxigenic Escherichia coli-related post-weaning diarrhoea in a Danish nursery pig herd not using medicinal zinc oxide
by: Malene Kjelin Morsing, et al.
Published: (2022-11-01)

Enterotoxigenic Escherichia coli and Vibrio cholerae Diarrhea, Bangladesh, 2004
by: Firdausi Qadri, et al.
Published: (2005-07-01)

Consensus report on Shigella controlled human infection model: conduct of studies
by: Talaat, K, et al.
Published: (2019)

Shigella
Published: (2009-03-01)